News All PostNewsFast Forward, Juvenile Diabetes Research Foundation and Axxam SpA join Forces to Accelerate Development of Treatments for Multiple Sclerosis and…8 January 2010read more >Dompé farmaceutici and Axxam Announce the Extension of Their Drug Discovery and Development Collaboration28 August 2009read more >CyBio and Axxam Develop a New System for High Throughput Screening – Expanding Capabilities in Robotic HTS20 March 2009read more >InterMed Discovery GmbH and Axxam SpA Announce Joint Research Agreement for the Identification of Novel Natural Functional Ingredients5 March 2009read more >Axxam awarded substantial funding by the Regione Lombardia (Metadistretti) to support an innovative drug discovery project20 December 2008read more >Axxam announces the acquisition of molecular screening technologies and related intellectual property rights from Bayer HealthCare AG22 October 2008read more >Load MoreEnd of Content.
Fast Forward, Juvenile Diabetes Research Foundation and Axxam SpA join Forces to Accelerate Development of Treatments for Multiple Sclerosis and…8 January 2010read more >
Dompé farmaceutici and Axxam Announce the Extension of Their Drug Discovery and Development Collaboration28 August 2009read more >
CyBio and Axxam Develop a New System for High Throughput Screening – Expanding Capabilities in Robotic HTS20 March 2009read more >
InterMed Discovery GmbH and Axxam SpA Announce Joint Research Agreement for the Identification of Novel Natural Functional Ingredients5 March 2009read more >
Axxam awarded substantial funding by the Regione Lombardia (Metadistretti) to support an innovative drug discovery project20 December 2008read more >
Axxam announces the acquisition of molecular screening technologies and related intellectual property rights from Bayer HealthCare AG22 October 2008read more >